GM Says Sales To Commercial, Government And Rental Fleets Grew 29% YoY; Says Saw ‘Significant pent-up demand for GM vehicles amid low inventories’

Key Takeaways: Akeso swung to an annual profit of 1.94 billion yuan, boosted by licensing income of 2.92 billion yuan The next highly anticipated product in the firm’s drug pipeline is ivonescimab, the first PD-1/VEGF bispecific antibody to enter Phase III clinical trials By Molly Wen